| Target Price | $216.24 |
| Price | $247.12 |
| Deviation |
12.50%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target Alexander's, Inc. 2027 .
The average Alexander's, Inc. target price is $216.24.
This is
12.50%
register free of charge
$222.60
9.92%
register free of charge
$214.12
13.35%
register free of charge
|
|
| A rating was issued by 8 analysts: 0 Analysts recommend Alexander's, Inc. to buy, 2 to hold and 6 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Alexander's, Inc. stock has an average upside potential 2027 of
12.50%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 213.18 | 210.30 |
| 5.83% | 1.35% |
1 Analyst has issued a sales forecast Alexander's, Inc. 2026 . The average Alexander's, Inc. sales estimate is
This results in the following potential growth metrics:
| 2025 | $213m | 5.83% |
|---|---|---|
| 2026 |
$210m
1.35%
unlock
|
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| EV/Sales | 8.66 |
Based on analysts' sales estimates for 2026, the Alexander's, Inc. stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
| Current | 8.35 | 3.24% |
|---|---|---|
| 2026 |
8.66
3.72%
unlock
|
|
| Current | 5.88 | 6.21% |
|---|---|---|
| 2026 |
5.48
6.67%
unlock
|
|
Alexander's, Inc....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jul 21 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jul 21 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


